Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Gastrointestinal Cancers
•
Medical Oncology
Which adjuvant chemotherapy would you offer to a MSI high pancreatic cancer patient after Whipple?
Answer from: Medical Oncologist at Community Practice
Not yet ready for IO alone. Can add IO to FFX maybe.
Sign in or Register to read more
20162
Related Questions
Would you use adagrasib in combination with cetuximab based on recently published article in NEJM for metastatic colon cancer with KRAS G12C mutation?
For T3N0 rectosigmoid tumors who get surgery upfront, what is your preferred adjuvant therapy?
How would you manage a patient with T4N1 duodenal adenocarcinoma by EUS with ampullary invasion that is dMMR?
How long should surgery be delayed in a patient with localized, resectable pancreatic cancer who developed acute pancreatitis following EUS guided biopsy?
For inoperable cholangiocarcinoma, do you recommend up-front chemotherapy prior to offering SBRT or combination chemoradiation?
How do you employ focal therapies in localized hepatocellular carcinoma?
What are your top takeaways from ASCO GI 2024?
How, if at all, are you employing ctDNA in the management of patients with colon cancer?
How would you manage a patient with metastatic HCC on atezolizumab/bevacizumab who requires holding bevacizumab due to persistent proteinuria >2g?
How will the PROSPECT trial presented at ASCO 2023 change your current management of early rectal cancer?